Aromasin
Drug timelines are a Plus or Pro feature.
55 regulatory and trial events tracked for Aromasin, covering 2006-09-19 to 2025-12-23. Get the full timeline:
Most recent: Clinical Trial Update: An Exploratory Study of Pertuzumab and Trastuzumab in Combination With Palbociclib and Exemestane as Neoadjuvant Therapy for Triple-Positive Breast Cancer [Phase 2]